AIG
ELDN icon

American International Group’s Eledon Pharmaceuticals ELDN Stock Holding History

American International Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-38
Closed -$5K – 3088
2017
Q1 		$5K Buy
38
+3
+9% +$441 ﹤0.01% 2994
2016
Q4 		$6K Hold
35
– – ﹤0.01% 2997
2016
Q3 		$8.74K Hold
35
– – ﹤0.01% 3020
2016
Q2 		$31.4K Buy
35
+1
+3% +$1.1K ﹤0.01% 3022
2016
Q1 		$31K Hold
34
– – ﹤0.01% 4117
2015
Q4 		$48K Hold
34
– – ﹤0.01% 3929
2015
Q3 		$58K Hold
34
– – ﹤0.01% 3840
2015
Q2 		$73.9K Buy
34
+11
+48% +$21.3K ﹤0.01% 3868
2015
Q1 		$42K Hold
23
– – ﹤0.01% 4051
2014
Q4 		$54.8K Buy
+23
New +$54.6K ﹤0.01% 3937

Other funds holding ELDN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

American International Group's ELDN Position: Q2 2017 in Review

American International Group sold out of Eledon Pharmaceuticals (ELDN) in Q2 2017, closing a stake of 38 shares — an estimated $5K sold.

American International Group first reported a position in ELDN in Q4 2014 and held it in 10 quarters. The position peaked at $73.9K in Q2 2015. 19 funds tracked by Wall St. Rank hold ELDN as of Q2 2017.

  • American International Group reported no remaining Eledon Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • American International Group sold 38 Eledon Pharmaceuticals shares in Q2 2017, an estimated $5K.
  • American International Group first reported a position in Eledon Pharmaceuticals in Q4 2014 and held it in 10 quarters.
  • American International Group's Eledon Pharmaceuticals position peaked at $73.9K in Q2 2015.
  • 19 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.